New drug development company set up in the Benelux

Thursday 26 August 2010

A new company has been set up in the Benelux to discover and develop small molecule drugs for treating bone and joint diseases. It combines assets from TiGenix NV of Belgium and Therosteon BV of the Netherlands.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Belgium